<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Harv Rev Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Harv Rev Psychiatry</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Harvard review of psychiatry</journal-title></journal-title-group><issn pub-type="ppub">1067-3229</issn><issn pub-type="epub">1465-7309</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11060627</article-id><article-id pub-id-type="pmcid-ver">PMC11060627.1</article-id><article-id pub-id-type="pmcaid">11060627</article-id><article-id pub-id-type="pmcaiid">11060627</article-id><article-id pub-id-type="manuscript-id">NIHMS1933137</article-id><article-id pub-id-type="pmid">37948154</article-id><article-id pub-id-type="doi">10.1097/HRP.0000000000000384</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1933137</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1933137</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Towards a Psychological Model of Chemical Coping with Opioids in Cancer Care</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Yusufov</surname><given-names initials="M">Miryam</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pirl</surname><given-names initials="WF">William F.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Braun</surname><given-names initials="I">Ilana</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sannes</surname><given-names initials="T">Timothy</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McHugh</surname><given-names initials="RK">R. Kathryn</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Dana-Farber Cancer Institute, Department of Psychosocial Oncology &amp; Palliative Care, 450 Brookline Avenue, Boston, MA 02215</aff><aff id="A2"><label>2</label>McLean Hospital, Center of Excellence in Alcohol, Drugs, and Addiction, 115 Mill Street, Belmont, MA 02478</aff><aff id="A3"><label>3</label>Harvard Medical School, Boston, MA 02115</aff><author-notes><corresp id="CR1"><label>*</label><underline>Corresponding Author</underline>: Miryam Yusufov, PhD, Dana-Farber Cancer Institute, Department of Psychosocial Oncology and Palliative Care, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215, United States, <email>miryam_yusufov@dfci.harvard.edu</email></corresp><fn fn-type="COI-statement" id="FN1"><p id="P33"><bold>Declaration of interest:</bold> We have no conflicts of interest to disclose.</p></fn></author-notes><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2023</year></pub-date><volume>31</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">461308</issue-id><fpage>259</fpage><lpage>266</lpage><pub-history><event event-type="nihms-submitted"><date><day>28</day><month>03</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>30</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>30</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 19:25:12.460"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1933137.pdf"/><abstract id="ABS1"><p id="P1">Most patients with advanced cancer receive treatment for related pain. Opioid accessibility, however, is a risk factor for misuse, which can present care challenges and quality-of-life concerns. There is lack of consistent universal screening prior to initiation of opioid prescribing. One crucial issue in treating this population is adequately identifying and mitigating risk factors driving opioid misuse. Drawing on theory and research from addiction science, psychology, palliative care, and oncology, the presented conceptual framework suggests that risk factors for opioid misuse during cancer care can be stratified into historical, current, malleable, and unmalleable factors. The framework identifies necessary factors to address to mitigate risk for opioid misuse during cancer care, and offers key directions for future research.</p></abstract><kwd-group><kwd>addiction</kwd><kwd>cancer</kwd><kwd>chemical coping</kwd><kwd>oncology</kwd><kwd>opioids</kwd><kwd>substance use disorders</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>